Previous 10 | Next 10 |
home / stock / innpf / innpf news
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful preclinical trials in dogs with osteoarthritis. A case entailing the clinical condition of G...
Innocan Pharma (OTCQB:INNPF), a company developing cannabis-based treatments, on Friday said it had filed a new patent application for a treatment for vaginal atrophy. Vaginal atrophy is a condition associated with loss of moisture, thinning, and inflammation of the vaginal walls, which can b...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed a new PCT patent application entitled "Compositions for Treatment of Vaginal Atrophy"...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 10, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the successful preliminary results of a small-scale efficacy trial in dogs with refractory (drug-resist...
Innocan Pharma press release (OTCQB:INNPF): Q1 GAAP EPS of $0.00. Revenue of $0.26M (+550.0% Y/Y). For further details see: Innocan Pharma GAAP EPS of $0.00, revenue of $0.26M
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 30, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is proud to report its financial results for the quarter ended March 31, 2022. First Quarter 2022 Financial and Operatin...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the " Company " or " Innocan ") is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the " Base Sh...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that an International Patent Application ("PCT") titled "Protein-bound Cannabinoid Formulations and Uses...
A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is proud to announce the publication of a case report regarding i...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to report the "accepted for publication" of a Case Report Article describing subcutaneously injected liposomal ca...
News, Short Squeeze, Breakout and More Instantly...
Innovative Properties Inc Company Name:
INNPF Stock Symbol:
OTCMKTS Market:
Innovative Properties Inc Website:
Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting Canada NewsWire HERZLIYA, Israel and CALGARY , Alberta , July 2, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"),...
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a...
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan...